1. Home
  2. LARK vs LUCD Comparison

LARK vs LUCD Comparison

Compare LARK & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

HOLD

Current Price

$27.58

Market Cap

171.0M

Sector

Finance

ML Signal

HOLD

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.02

Market Cap

190.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LARK
LUCD
Founded
1885
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.0M
190.8M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
LARK
LUCD
Price
$27.58
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
3.5K
839.4K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
3.07%
N/A
EPS Growth
35.84
16.67
EPS
0.83
N/A
Revenue
N/A
$4,346,000.00
Revenue This Year
N/A
$115.58
Revenue Next Year
N/A
$130.54
P/E Ratio
$33.46
N/A
Revenue Growth
N/A
79.00
52 Week Low
$23.43
$0.95
52 Week High
$30.80
$1.70

Technical Indicators

Market Signals
Indicator
LARK
LUCD
Relative Strength Index (RSI) 51.32 34.52
Support Level $27.01 N/A
Resistance Level $28.76 $1.12
Average True Range (ATR) 0.85 0.05
MACD -0.02 -0.00
Stochastic Oscillator 57.50 27.74

Price Performance

Historical Comparison
LARK
LUCD

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and Southwest Kansas.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: